期刊文献+

SLE患者T细胞PKA活性及血清因子对PKA活性的影响

Study on PKA Activity of T Cells from Patients with SLE and Serum Factor on PKA Activity in Normal T Cells
下载PDF
导出
摘要 目的:研究SLE患者T细胞功能异常是否与T细胞CA/cAMP/PKA信号传导途径存在异常有关,探讨SLE的发病机理。方法:用尼龙柱分离肝素化的静脉血得到T细胞悬液,用流式细胞术测定CD_3阳性细胞90%以上,用CD_3单抗与羊抗鼠二抗IgG相交联和rIL-1α共同刺激T细胞24 小时,用RT-PCR检测IL-2和IL-2R mRNA的表达,证实T细胞是否活化。用PKA检测试剂盒检测T细胞PKA总体活性变化,用SLE血清或含不同浓度IFN-α的完全培养基和正常人T细胞培养24小时,然后用上述方法激活T细胞,分别测量T细胞PKA的总体活性。结果:SLE患者T细胞活化后PKA总体活性是下降的,SLE患者血清免疫复合物及不同浓度的IFN-α都不能使正常人T细胞的PKA总体活性下降。SLE患者T细胞活化后总体PKA活性下降和血清中的免疫复合物及血中高浓度的IFN-α无关。结论:1,SLE患者T细胞CA/cAMP/PKA信号传导途径存在异常。2,SLE患者T细胞功能异常是原发的,是由于细胞内生物化学信号途径异常所致。 Objective:To demonstrate the relationship between SUE T cells primary function disorder and abnormal AC/cAMP/PKA biochemical pathways. Methods: Human T lymphocytes were isolated by nylon immunoaffinity columns, T lymphocytes were isolated and enriched from PBMC by nylon im-munoaffinity columns, cytofluorographic analysis of enriched T lymphocyte over 90% possessed the CD3 membrane complex. SLE and control T cells were activated in vitro by monoclonal anti - CD3-ε antibody cross - linking sheep anti - mouse antibody IgG and recombinant IL -1 α(rIL - 1α) for 24 hours, T cells activation was verified by IL - 2 mRNA, IL - 2R - α, mRNA and IL - 2R - β mRNA expression . Total PKA activity of T cells was quantified by liquid scintillation spectrometry. Results: Total PKA activity of SLE T cells diminished after T cell activation. Neither SLE sera or IFN - a showed on any infnence on total PKA activity in control. Conclusion: T cells from active SLE possesed a metabolic disorder of the AC/cAMP/PKA pathway. A primary T cell disorder existing in SLE is the by - product of abnormal biochemical pathways.
出处 《岭南皮肤性病科杂志》 2002年第4期235-238,共4页 Southern China Journal of Dermato-Venereology
关键词 T细胞 SLE 患者 PKA 血清 IFN 活性 中高 交联 尼龙 Systemic lupus erythematosus T cells TCR/CD3 IL - 2
  • 相关文献

参考文献7

  • 1Hasler P, Schultz LA, Kammer GM. Defective cAMP- dependent phosphorylation of intact T lymphocytes in active systemic lupus erythematosus[J]. Proc Natl Acad Sci USA, 1990, 87(1): 1978~ 1982.
  • 2Inghirami G, Simon J, Balow J E, et al. Activated T lymphocytes in the peripheral blood ot patients with systemic lupus erythematosus induce B cells to produce immumoglobulin[J]. Clin Exp Rheumatol, 1998, 6( 1 ): 269 ~ 276.
  • 3Kim T, Kanayama Y, Negoro N, et al. Serum levels of interferons in patients with systemic lupus erythematosus [J]. Clin Exp Immunol, 1987, 70(3): 562 ~ 569.
  • 4Tsokos GC. Overview of cellular immune function in systemic lupus erythematosus[M]. La Hita RG, ed, Churachill Livingstone, New York, 1992, 13.
  • 5Goldschmidt LP, Kresina TF, Kammer GM. Effect of anti-T cell autoantibodies from systemic lupus erythematosus sera upon T lymphocyte functions[J]. Arthritis Rheum, 1986, 29(2):646 ~ 654.
  • 6Yamamoto KK, Gonzalez GA, Biggs WH, et al. Phosphorylation- induced binding and transcriptional efficacy of nuclear factor CREB [J]. Nature, 1988, 334(2): 494 ~ 498.
  • 7Tada Y,. Nagasawa K, Yamauchi Y, et al. A defect in the protein kinase C system in T cells from patients with systemic lupus erythematosus [ J ]. Clin Immunol Immununopathol,1991, 60(1): 220~231.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部